Skip to content
Testa Center logo — A test bed for biology and technology for production of biol...

Testa Center

A test bed for biology and technology for production of biological products

Founded 2016 Sweden Sweden 8 employees Biotechnology, Pharmaceutical +1

General Information

Company Name Testa Center
Founded Year 2016
Location Sweden Sweden
Employees 8
Industries Biotechnology, Pharmaceutical, Marketing
Social

BounceWatch is an independent company data service, not affiliated with Testa Center. To contact Testa Center, visit testacenter.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Testa Center compare?

A PDF of Testa Center and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Testa Center soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Testa Center

Testa Center is a Swedish-based startup that serves as a test bed for biology and technology for the production of biological products. Founded in 2016, the company operates in the biotechnology and pharmaceutical industries, positioning itself at the intersection of cutting-edge biological research and technological innovation. The company has not disclosed its last investment round, including details about the investors or the investment amount, which could be indicative of various scenarios, such as a self-sufficient financial position, ongoing private funding negotiations, or a strategic preference for non-disclosure. Overall, Testa Center's pioneering role in bridging biology and technology underscores its potential to drive innovation in the production of biological products, providing an attractive opportunity for venture capital firms seeking impactful investments within the biotech and pharmaceutical sectors.

Business keywords: Cell Therapy, Chromatography, Pharmaceuticals, Biological Products, Monoclonal Antibodies, Peptides, Protein Production, Vaccine Production, Viral Vectors, Pilot-Scale Testbed, Biology, Technology, Production

No funding data available for Testa Center yet.

Testa Center Alternatives & Competitors

View All Alternatives
Testa Center vs
Chromaprobe Inc
Chromaprobe Inc United States

Leading Innovation in Biotechnology: Advancing Flow Cytometry, Cytochemistry, and Molecular Biology...

2-10 employees
Biotechnology, Pharmaceutical
Testa Center vs
FogPharma
FogPharma United States

Until everything is druggable.

Series E
146 employees
Biopharma, Biotechnology
Testa Center vs

Repligen, a global, bioprocessing-focused life sciences company, provides innovative solutions for t...

Post-IPO Debt
1470 employees
Analytics, Biotechnology

FAQ About Testa Center

A test bed for biology and technology for production of biological products
Testa Center was founded in 2016.
Testa Center is headquartered in Sweden.
Testa Center operates in Biotechnology, Pharmaceutical and Marketing. Its work centres on Cell Therapy, Chromatography, Pharmaceuticals and Biological Products.
Testa Center has approximately 8 employees.
Top alternatives and competitors to Testa Center include Chromaprobe Inc, FogPharma, Repligen Corporation, BI Biotech India Pvt. Ltd., ProBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Testa Center and Chromaprobe Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Testa Center, https://bouncewatch.com/company/testa-center, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout